These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2992269)

  • 1. Association between urinary zinc excretion and lymphocyte dysfunction in patients with lung cancer.
    Allen JI; Bell E; Boosalis MG; Oken MM; McClain CJ; Levine AS; Morley JE
    Am J Med; 1985 Aug; 79(2):209-15. PubMed ID: 2992269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum zinc levels and urinary zinc excretion in patients with bronchogenic carcinoma. Effects of tumor resection.
    Voyatzoglou V; Mountokalakis T; Tsata-Voyatzoglou V; Koutselinis A; Skalkeas G
    Am J Surg; 1982 Sep; 144(3):355-8. PubMed ID: 7114378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of zinc supplementation in type II diabetes mellitus.
    Niewoehner CB; Allen JI; Boosalis M; Levine AS; Morley JE
    Am J Med; 1986 Jul; 81(1):63-8. PubMed ID: 3728555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency.
    Allen JI; Perri RT; McClain CJ; Kay NE
    J Lab Clin Med; 1983 Oct; 102(4):577-89. PubMed ID: 6604771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc and T-lymphocyte function in hemodialysis patients.
    Allen JI; Korchik W; Kay NE; McClain CJ
    Am J Clin Nutr; 1982 Sep; 36(3):410-5. PubMed ID: 6981341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urine zinc response in head-injured patients.
    McClain CJ; Twyman DL; Ott LG; Rapp RP; Tibbs PA; Norton JA; Kasarskis EJ; Dempsey RJ; Young B
    J Neurosurg; 1986 Feb; 64(2):224-30. PubMed ID: 3944632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of oral zinc supplementation on the lymphocyte response to mitogens of normal subjects.
    Duchateau J; Delespesse G; Vereecke P
    Am J Clin Nutr; 1981 Jan; 34(1):88-93. PubMed ID: 7446464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of zinc supplementation on glucose homeostasis in NIDDM.
    Raz I; Karsai D; Katz M
    Diabetes Res; 1989 Jun; 11(2):73-9. PubMed ID: 2695282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial.
    Barnett JB; Dao MC; Hamer DH; Kandel R; Brandeis G; Wu D; Dallal GE; Jacques PF; Schreiber R; Kong E; Meydani SN
    Am J Clin Nutr; 2016 Mar; 103(3):942-51. PubMed ID: 26817502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck.
    Wanebo HJ; Jones T; Pace R; Cantrell R; Levine P
    Am J Surg; 1989 Oct; 158(4):356-60. PubMed ID: 2802041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc reverses the increased sensitivity of lymphocytes from aged subjects to the antiproliferative effect of prostaglandin E2.
    Santos-Neto L; Tosta CE; Dorea JG
    Clin Immunol Immunopathol; 1992 Sep; 64(3):184-7. PubMed ID: 1643750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A in carcinoma of the lung.
    Benson MD; Eyanson S; Fineberg NS
    Cancer; 1986 May; 57(9):1783-7. PubMed ID: 3006907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary and serum zinc levels in chronic pancreatitis.
    Kondo T; Hayakawa T; Shibata T; Kitagawa M; Sakai Y; Ono H
    Pancreas; 1989; 4(1):79-82. PubMed ID: 2717604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma.
    Pitchenik AE; Guffee J; Stein-Streilein J
    Am Rev Respir Dis; 1987 Dec; 136(6):1327-32. PubMed ID: 3500659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by bronchial lavage cells in normal individuals and patients with bronchogenic carcinoma.
    Weissman DN; deShazo RD; Banks DE; Baser Y
    Am J Med Sci; 1986 Oct; 292(4):187-92. PubMed ID: 3019138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous bleeding related to zinc deficiency in two cases of advanced cancer.
    Stefanini M
    Cancer; 1999 Sep; 86(5):866-70. PubMed ID: 10463987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.